<h4>Importance</h4>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are fast-growing treatments for type 2 diabetes, obesity, and sleep apnea and are under investigation as potential treatments for many other conditions. Here, GLP1R is linked to sleep apnea syndrome.